Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Asthma drugs and the risk of congenital anomalies.

Vasilakis-Scaramozza C, Aschengrau A, Cabral HJ, Jick SS.

Pharmacotherapy. 2013 Apr;33(4):363-8. doi: 10.1002/phar.1213. Epub 2013 Feb 28.

PMID:
23450814
2.

Antihypertensive drugs and the risk of congenital anomalies.

Vasilakis-Scaramozza C, Aschengrau A, Cabral HJ, Jick SS.

Pharmacotherapy. 2013 May;33(5):476-82. doi: 10.1002/phar.1212. Epub 2013 Apr 1.

PMID:
23553869
3.

Antidepressant use during early pregnancy and the risk of congenital anomalies.

Vasilakis-Scaramozza C, Aschengrau A, Cabral H, Jick SS.

Pharmacotherapy. 2013 Jul;33(7):693-700. doi: 10.1002/phar.1211. Epub 2013 Jun 6.

PMID:
23744675
4.

Maternal asthma, asthma medication use, and the risk of congenital heart defects.

Lin S, Herdt-Losavio M, Gensburg L, Marshall E, Druschel C.

Birth Defects Res A Clin Mol Teratol. 2009 Feb;85(2):161-8. doi: 10.1002/bdra.20523.

PMID:
19067406
5.

Valproic acid monotherapy in pregnancy and major congenital malformations.

Jentink J, Loane MA, Dolk H, Barisic I, Garne E, Morris JK, de Jong-van den Berg LT; EUROCAT Antiepileptic Study Working Group.

N Engl J Med. 2010 Jun 10;362(23):2185-93. doi: 10.1056/NEJMoa0907328. Review.

6.

Asthma exacerbations during the first trimester of pregnancy and congenital malformations: revisiting the association in a large representative cohort.

Blais L, Kettani FZ, Forget A, Beauchesne MF, Lemière C.

Thorax. 2015 Jul;70(7):647-52. doi: 10.1136/thoraxjnl-2014-206634. Epub 2015 Apr 17.

PMID:
25888364
7.

Beta2-agonists use during pregnancy and the risk of congenital malformations.

Eltonsy S, Forget A, Blais L.

Birth Defects Res A Clin Mol Teratol. 2011 Nov;91(11):937-47. doi: 10.1002/bdra.22850. Epub 2011 Sep 22.

PMID:
21948561
8.

First trimester exposure to anxiolytic and hypnotic drugs and the risks of major congenital anomalies: a United Kingdom population-based cohort study.

Ban L, West J, Gibson JE, Fiaschi L, Sokal R, Doyle P, Hubbard R, Smeeth L, Tata LJ.

PLoS One. 2014 Jun 25;9(6):e100996. doi: 10.1371/journal.pone.0100996. eCollection 2014.

9.

Treatment of graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation.

Yoshihara A, Noh J, Yamaguchi T, Ohye H, Sato S, Sekiya K, Kosuga Y, Suzuki M, Matsumoto M, Kunii Y, Watanabe N, Mukasa K, Ito K, Ito K.

J Clin Endocrinol Metab. 2012 Jul;97(7):2396-403. doi: 10.1210/jc.2011-2860. Epub 2012 Apr 30.

PMID:
22547422
10.

Selective serotonin reuptake inhibitors and congenital heart anomalies: comparative cohort studies of women treated before and during pregnancy and their children.

Petersen I, Evans SJ, Gilbert R, Marston L, Nazareth I.

J Clin Psychiatry. 2016 Jan;77(1):e36-42. doi: 10.4088/JCP.14m09241.

PMID:
26845280
11.

Selective serotonin reuptake inhibitor antidepressant use in first trimester pregnancy and risk of specific congenital anomalies: a European register-based study.

Wemakor A, Casson K, Garne E, Bakker M, Addor MC, Arriola L, Gatt M, Khoshnood B, Klungsoyr K, Nelen V, O'Mahoney M, Pierini A, Rissmann A, Tucker D, Boyle B, de Jong-van den Berg L, Dolk H.

Eur J Epidemiol. 2015 Nov;30(11):1187-98. doi: 10.1007/s10654-015-0065-y. Epub 2015 Jul 7.

PMID:
26148560
12.

Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study.

Jentink J, Dolk H, Loane MA, Morris JK, Wellesley D, Garne E, de Jong-van den Berg L; EUROCAT Antiepileptic Study Working Group.

BMJ. 2010 Dec 2;341:c6581. doi: 10.1136/bmj.c6581. Review.

13.

The Xolair Pregnancy Registry (EXPECT): the safety of omalizumab use during pregnancy.

Namazy J, Cabana MD, Scheuerle AE, Thorp JM Jr, Chen H, Carrigan G, Wang Y, Veith J, Andrews EB.

J Allergy Clin Immunol. 2015 Feb;135(2):407-12. doi: 10.1016/j.jaci.2014.08.025. Epub 2014 Oct 19.

PMID:
25441639
14.

Anticonvulsants and congenital malformations.

Jick SS, Terris BZ.

Pharmacotherapy. 1997 May-Jun;17(3):561-4.

PMID:
9165559
15.

Use of cimetidine, omeprazole, and ranitidine in pregnant women and pregnancy outcomes.

Ruigómez A, García Rodríguez LA, Cattaruzzi C, Troncon MG, Agostinis L, Wallander MA, Johansson S.

Am J Epidemiol. 1999 Sep 1;150(5):476-81.

PMID:
10472947
16.

Effect of maternal asthma on the risk of specific congenital malformations: A population-based cohort study.

Blais L, Kettani FZ, Elftouh N, Forget A.

Birth Defects Res A Clin Mol Teratol. 2010 Apr;88(4):216-22. doi: 10.1002/bdra.20651.

PMID:
20099316
17.

Pregabalin use early in pregnancy and the risk of major congenital malformations.

Patorno E, Bateman BT, Huybrechts KF, MacDonald SC, Cohen JM, Desai RJ, Panchaud A, Mogun H, Pennell PB, Hernandez-Diaz S.

Neurology. 2017 May 23;88(21):2020-2025. doi: 10.1212/WNL.0000000000003959. Epub 2017 Apr 26.

PMID:
28446648
18.

Effect of maternal asthma, exacerbations and asthma medication use on congenital malformations in offspring: a UK population-based study.

Tata LJ, Lewis SA, McKeever TM, Smith CJ, Doyle P, Smeeth L, Gibson JE, Hubbard RB.

Thorax. 2008 Nov;63(11):981-7. doi: 10.1136/thx.2008.098244. Epub 2008 Aug 4.

PMID:
18678701
19.

Use of inhaled corticosteroids during the first trimester of pregnancy and the risk of congenital malformations among women with asthma.

Blais L, Beauchesne MF, Rey E, Malo JL, Forget A.

Thorax. 2007 Apr;62(4):320-8. Epub 2006 Nov 22.

20.

Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011.

Floridia M, Mastroiacovo P, Tamburrini E, Tibaldi C, Todros T, Crepaldi A, Sansone M, Fiscon M, Liuzzi G, Guerra B, Vimercati A, Vichi F, Vicini I, Pinnetti C, Marconi AM, Ravizza M; Italian Group on Surveillance on Antiretroviral Treatment in Pregnancy.

BJOG. 2013 Nov;120(12):1466-75. doi: 10.1111/1471-0528.12285. Epub 2013 May 31.

Supplemental Content

Support Center